Clinical Trial Update: Adenoid Cystic Carcinoma, Erbitux, and Particle Therapy [Phase 1, Phase 2]

View source ↗

Summary

An update on Phase 1/2 trials evaluating cetuximab (Erbitux) in combination with particle therapy for Adenoid cystic carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• ERBITUX (cetuximab)

Snippet

Sponsor: Heidelberg University | Conditions: Adenoid Cystic Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN